ALEFACEPT
UNII ELK3V90G6C

Substance Identification & Data

This profile provides standardized clinical and technical data for Alefacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ELK3V90G6C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 222535-22-0 and the RxNorm Concept ID (RxCUI) 299635. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ELK3V90G6C
CAS Registry Number
222535-22-0
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
ALEFACEPT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8059
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LL-29
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alefacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALEFACEPT

Common Names & Synonyms

1-92-ANTIGEN LFA 3 (HUMAN) FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G 1 (HINGE-CH2-CH3 .GAMMA.1-CHAIN), DIMER
1-92-LFA-3 (ANTIGEN) (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN HINGE-CH2-CH3 .GAMMA.1-CHAIN), DIMER
ALEFACEPT [INN]
ALEFACEPT [MART.]
ALEFACEPT [MI]
ALEFACEPT [USAN]
ALEFACEPT [VANDF]
ALEFACEPT [WHO-DD]
HUMAN LFA-3IGG FUSION PROTEIN
RECOMBINANT HUMAN LFA-3/IGG.SUB(1). FUSION PROTEIN

Brand / Trade Names

AMEVIVE

Technical Codes

BG9273
BG-9273
BG9712
BG-9712
LFA-3CD2
LFA3TIP
LFA-3TIP